PN
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
1.332
Exchange
XNAS - Nasdaq
0.34 B
Last period Cash and equivalents ,USD
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also POINT Biopharma
Company Analysis
PNT valuation, rating, competitors, insights and company profile
Eyestock Rating
PNT financial analysis by Eyestock methodology
Valuation
PNT valuation using historical relative method
Statements
PNT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PNT dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
POINT Biopharma`s Cash and equivalents for the period ended 2023-09-30 are 0.34 B USD
